Clinical Trial Update: A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen [Phase 1]

View source ↗

Summary

Phase 1 study comparing patient preference between ZP-PTH Patch and Forteo Pen in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Forteo Pen (teriparatide)
• ZP-PTH Patch (parathyroid hormone patch)

Snippet

Sponsor: Zosano Pharma Corporation | Conditions: Postmenopausal Osteoporosis | Phase 1 | Status: COMPLETED